# Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

> **NCT05054296** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 200 (estimated)

## Conditions studied

- Biochemically Recurrent Prostate Carcinoma
- Metastatic Prostate Adenocarcinoma
- Stage IV Prostate Cancer AJCC v8
- Stage IVA Prostate Cancer AJCC v8
- Stage IVB Prostate Cancer AJCC v8

## Interventions

- **BEHAVIORAL:** Educational Intervention
- **BEHAVIORAL:** Exercise Intervention
- **DEVICE:** FitBit
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT05054296
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-23
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-02-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05054296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05054296, "Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05054296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*